Список проголосовавших за комментарий " Gapping up/down: HQY +6%, GWPH +6%, GPS +4% and GM +1.5% after earnings, CAT and BIIB +2% after upgrades; KORS -7%, MOS -7%, BP -4%, and LMNX -2% after earnings<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong>RE</strong> +8.1%, <strong>JLL</strong> +7.8%, <strong>PMD</strong> +7.2%, <strong>AVXL</strong> +6.5%, <strong>HQY</strong> +6.4%, <strong>GWPH</strong> +6%, <strong>ACM</strong> +5.7%, <strong>ALSN</strong> +5.1% (also will buyback all of ValueAct's holdings)</li><li><strong>WWW</strong> +4.4% (announces leadership appointments; indicates quarterly results were in-line with expectations), <strong>FN</strong> +4.4%, <strong>NOV</strong> +3.2%, <strong>ITUB</strong> +3.2%</li><li><strong>GPS</strong> +2.7% (issued upside Q4 guidance and reported January same store sales +1%)</li><li><strong>TDG</strong> +2.2%, <strong>PAHC</strong> +2%, <strong>EMR</strong> +1.8%, <strong>GM</strong> +1.5%, <strong>CHD</strong> +1.4%, <strong>CNC</strong> +1%, <strong>QSR</strong> +0.8%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>PIP</strong> +22.8% (continued strength following yesterday's 159% move)</li><li><strong>ADHD</strong> +11.5% (announces FDA meeting on its ADAIR product candidate defined a 505(b)(2) development path, to be funded with existing cash balance, and targeting a 2H 2018 NDA submission)</li><li><strong>DRYS</strong> +6.6% (after closing near highs — up 30% on the day)</li><li><strong>GLBS</strong> +4.6% (after closing near highs — up 20% on the day)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>ATHX</strong> +8.6% (initiated with a Buy at Needham; tgt $7)</li><li><strong>NOK</strong> +2.1% (upgraded to Overweight from Equal-Weight at Morgan Stanley)</li><li><strong>CAT</strong> +1.7% (upgraded to Overweight from Equal Weight at Barclays)</li><li><strong>BIIB</strong> +1.7% (upgraded to Buy from Neutral at Citigroup)</li></ul><p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>GIGA</strong> -26.6%, <strong>KORS</strong> -7.3%, <strong>MOS</strong> -6.7%, <strong>ALLT</strong> -5.6%, <strong>YRCW</strong> -4.8%, <strong>FMC</strong> -4.4%, <strong>KN</strong> -4.3%, <strong>BP</strong> -3.6%, <strong>ARWR</strong> -3.2%, <strong>MAC</strong> -3%, <strong>LMNX</strong> -2.4%, <strong>VSH</strong> -2.4%</li><li><strong>TLLP</strong> -2%, <strong>STO</strong> -1.9%, <strong>BMI</strong> -1.8%</li><li><strong>AM</strong> -1.6%, (provides prelim Q4 results; announces the formation of a joint venture to develop processing and fractionation assets in Appalachia; increases 2017 guidance; prices/upsizes offering)</li><li><strong>GAIN</strong> -1.1%, <strong>FOXA</strong> -0.7%</li></ul><p><strong>Select EU financial related names showing weakness in sympathy with BNP Paribas (-5% in France after earnings)</strong>:</p><ul><li><strong>CS</strong> -0.9%, <strong>DB</strong> -0.6%, <strong>HSBC</strong> -0.5%, <strong>SAN</strong> -0.5%</li></ul><p><strong>Select metals/mining stocks trading lower</strong>:</p><ul><li><strong>AUY</strong> -2.5%, <strong>KGC</strong> -1.9%, <strong>HMY</strong> -1.4%, <strong>GFI</strong> -1.4%, <strong>ING</strong> -1.4%, <strong>NEM</strong> -1.2%, <strong>AU</strong> -1.1%, <strong>ABX</strong> -0.9%, <strong>AG</strong> -0.9%, <strong>GOLD</strong> -0.8%, <strong>GDX</strong> -0.8%, <strong>SLV</strong> -0.5%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>KTOV</strong> -23.9% (continued weakness on speculation of an investigation involving the company's CEO)</li><li><strong>FXCM</strong> -19.7% (confirms settlement with NFA and CFTC and non-binding letter of intent for GAIN Capital [GCAP] to purchase FXCM's U.S. customer accounts)</li><li><strong>AUPH</strong> -8.1% (Aurinia Pharma accepted the resignation of Charles Rowland as CEO and appointed Dr. Richard Glickman as new CEO)</li><li><strong>HLI</strong> -3.4% (commences 10 mln common stock offering, consisting of 7.5 mln shares offered by the co and 2.5 shares offered by certain of its employees and members of management)</li><li><strong>TEVA</strong> -3.3% (appoints Dr. Yitzhak Peterburg as Interim CEO succeeding Erez Vigodman and names Dr. Sol J. Barer as Chairman)</li><li><strong>EBAY</strong> -0.9% (eBay lower after disclosing material weakness in its internal control over financial reporting and filing mixed securities shelf offering)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>RH</strong> -4.6% (downgraded to Underperform from Neutral at Buckingham Research)</li><li><strong>AKG</strong> -1.6% (downgraded to Hold from Speculative Buy at Canaccord Genuity)</li><li><strong>CMO</strong> -1.2% (downgraded to Market Perform from Outperform at Wells Fargo)</li></ul>"